warnings
Warnings Stop use and ask a doctor if Symptoms persist for more than 7 days or worsen. If pregnant or breastfeeding Ask a health professional before use. Keep out of reach of children.
Nat Phos 6X
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Nat Phos 6X
- Generic name
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
- Manufacturer
- Hyland's Inc.
- Product type
- HUMAN OTC DRUG
- SPL set ID
- dc7c259e-4bcc-c3d9-e053-2a95a90a0c01
- SPL ID
- 3986984b-9ad7-f9e0-e063-6394a90a8cf7
- Version
- 3
- Effective date
- 2025-07-09
- Source export date
- 2026-10-12
- Source partition
- 5
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:40:32
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Nat Phos 6X | openfda.brand_name | |
| generic name | SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | openfda.generic_name | |
| manufacturer name | Hyland's Inc. | openfda.manufacturer_name | |
| ndc | package | 54973-4096-1 | openfda.package_ndc |
| ndc | product | 54973-4096 | openfda.product_ndc |
| ndc11 | package | 54973409601 | derived:openfda.package_ndc |
| spl id | 3986984b-9ad7-f9e0-e063-6394a90a8cf7 | id | |
| spl set id | dc7c259e-4bcc-c3d9-e053-2a95a90a0c01 | set_id | |
| unii | 70WT22SF4B | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.